From the ICC data, we determined that nuclear distribution of β-catenin was significantly decreased in both colon and breast cancer cells, whereas the localization of RAC1, the interacting partner of β-catenin, did not change in colon cancer cells, but its nuclear distribution decreased in breast cancer cells (Figure 5b). The gene discussed is RAC1; the disease is intrahepatic cholangiocarcinoma.